PendoPharm Inc. Sustainability Profile
PendoPharm Inc., a prominent player in the pharmaceutical industry, is headquartered in California and operates extensively across North America. Founded in 2015, the company has quickly established itself as a leader in the development and distribution of innovative healthcare solutions, particularly in the areas of specialty pharmaceuticals and medical devices. PendoPharm's core offerings include a range of unique products designed to address unmet medical needs, with a focus on improving patient outcomes. The company is recognised for its commitment to quality and efficacy, which has solidified its position in a competitive market. With a strong emphasis on research and development, PendoPharm continues to achieve significant milestones, contributing to advancements in healthcare and enhancing its reputation as a trusted partner in the industry.
DitchCarbon Score
How does PendoPharm Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
PendoPharm Inc.'s score of 23 is lower than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
PendoPharm Inc.'s reported carbon emissions
PendoPharm Inc., headquartered in California, currently does not report any specific carbon emissions data, as there are no available figures for emissions in kg CO2e. The company has not established documented reduction targets or climate pledges, indicating a lack of formal commitments to address carbon emissions at this time. As a current subsidiary, PendoPharm Inc. may inherit climate-related initiatives and targets from its parent organisation, but specific details regarding these cascaded commitments are not provided. Without concrete emissions data or reduction initiatives, it is challenging to assess PendoPharm's climate impact or commitments within the broader industry context.
How Carbon Intensive is PendoPharm Inc.'s Industry?
How Carbon Intensive is PendoPharm Inc.'s Location?
PendoPharm Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
PendoPharm Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
